Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rudge

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The Lancet. Neurology|March 19, 2022
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programmeSimon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.
Journal of Neurogenetics|January 10, 2025
The novel T107I Inherited prion disease can present as a clinical and biomarker mimic of familial Alzheimer's diseaseLeah Holm-Mercer, Thomas Coysh, Tze How Mok, et al.
JAMA Neurology|February 24, 2016
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob DiseaseSimon Mead, Matthew Burnell, Jessica Lowe, et al.
Clinical Immunology (Orlando, Fla.)|January 10, 2002
Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatmentUlrike H M Ziegner, Roger H Kobayashi, Charlotte Cunningham-Rundles, et al.
The New England Journal of Medicine|November 15, 2013
A novel prion disease associated with diarrhea and autonomic neuropathySimon Mead, Sonia Gandhi, Jon Beck, et al.
Brain : a Journal of Neurology|March 28, 2023
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion diseaseTze How Mok, Akin Nihat, Nour Majbour, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The Lancet. Neurology|March 19, 2022
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programmeSimon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.
Journal of Neurogenetics|January 10, 2025
The novel T107I Inherited prion disease can present as a clinical and biomarker mimic of familial Alzheimer's diseaseLeah Holm-Mercer, Thomas Coysh, Tze How Mok, et al.
JAMA Neurology|February 24, 2016
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob DiseaseSimon Mead, Matthew Burnell, Jessica Lowe, et al.
Clinical Immunology (Orlando, Fla.)|January 10, 2002
Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatmentUlrike H M Ziegner, Roger H Kobayashi, Charlotte Cunningham-Rundles, et al.
The New England Journal of Medicine|November 15, 2013
A novel prion disease associated with diarrhea and autonomic neuropathySimon Mead, Sonia Gandhi, Jon Beck, et al.
Brain : a Journal of Neurology|March 28, 2023
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion diseaseTze How Mok, Akin Nihat, Nour Majbour, et al.
Pageof 7